Is the Inflation Reduction Act a win for the Democrats?
The law is designed to reduce not only inflation but also carbon emissions and prescription drug costs
The passing by the Senate of a $750bn bill to tackle climate change, healthcare issues and soaring inflation is being heralded as a major victory for Joe Biden’s party ahead of the November mid-term elections.
The Democrat-endorsed Inflation Reduction Act represents “the largest climate investment in US history”, said CNN. The “sweeping” package is also designed to cut prescription drugs and to tackle soaring inflation by reducing the federal deficit by $300bn.
The product of “painstaking” negotiations, the act is expected to pass in the House of Representatives on Friday, the broadcaster added – and gives the Democrats the chance to “achieve major policy objectives ahead of the upcoming midterm elections”.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
What would the act deliver?
Democrats have argued that the act “will tackle voters’ main economic concern”, but Republicans insist the new spending will simply “aggravate inflation”, said NPR.
The non-partisan Congressional Budget Office has said the bill would have a “negligible” effect on inflation in 2022 and into 2023.
The bill would also allow the federal health secretary “to negotiate prescription drug prices with pharmaceutical companies”, said The Guardian. Insulin prices for Medicare patients would be capped at $35 a dose and expiring healthcare subsidies would be extended for three years.
But the planned measures won’t “impact every prescription drug or every patient”, said NPR, and “won’t take effect quickly”, starting with ten drugs covered by Medicare from 2026 and expanding to 20 drugs by 2029.
While the bill’s likely impact on inflation and healthcare problems are a matter of debate, plans to invest $370bn in clean energy and climate package mark the “biggest victory for the environmental movement since the landmark Clean Air Act”, according to CNN. Experts have estimated that the bill’s provisions will reduce US carbon emissions by up to 40% by 2030.
A domestic win for Biden?
Overall, the bill “is a very scaled-down” version of a $3.5trn proposal put forward by Biden and his party last year, said NPR.
But the bill still “delivers a much-needed domestic win” for Biden at a time when his “popularity has sunk”, said The Guardian. He “can now go to the polls and portray himself as a president able to get things done even in the difficult political circumstances of a deeply divided country”.
The hotly debated economic impact of the bill, and how that plays out with voters, remains to be seen though.
Tackling healthcare costs and boosting green energy may a “priority”, but it seems “disingenuous to claim that what makes up this bill will have a deflationary impact”, wrote Kate Andrews, The Spectator’s economics editor, in The Daily Telegraph. The “handouts” included are likely to “fuel inflation”, and “other aspects of the bill will work against economic growth”, she argued.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
6 charming homes for the whimsical
Feature Featuring a 1924 factory-turned-loft in San Francisco and a home with custom murals in Yucca Valley
By The Week Staff Published
-
Big tech's big pivot
Opinion How Silicon Valley's corporate titans learned to love Trump
By Theunis Bates Published
-
Stacy Horn's 6 favorite works that explore the spectrum of evil
Feature The author recommends works by Kazuo Ishiguro, Anthony Doerr, and more
By The Week US Published
-
How will home insurance change after LA's fires?
Today's Big Question Climate disasters leave insurance industry in crisis
By Joel Mathis, The Week US Published
-
The controversy over rewilding in the UK
The Explainer 'Irresponsible and illegal' release of four lynxes into Scottish Highlands 'entirely counterproductive' say conservationists
By The Week UK Published
-
What happens to wildlife during a wildfire?
The explainer Flames also affect the flora and fauna
By Devika Rao, The Week US Published
-
Biden cancels Italy trip as raging LA fires spread
Speed Read The majority of the fires remain 0% contained
By Peter Weber, The Week US Published
-
2024: the year of extreme hurricanes
In the Spotlight An eagle eye at a deadly hurricane season
By Devika Rao, The Week US Published
-
Chocolate is the latest climate change victim, but scientists may have solutions
Under the radar Making the sweet treat sustainable
By Devika Rao, The Week US Published
-
How would reaching net zero change our lives?
Today's Big Question Climate target could bring many benefits but global heating would continue
By Chas Newkey-Burden, The Week UK Published
-
Global plastics summit starts as COP29 ends
Speed Read Negotiators gathering in South Korea seek an end to the world's plastic pollution crisis, though Trump's election may muddle the deal
By Peter Weber, The Week US Published